MAINE MEDICAL CENTER
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Feb 13, 2018 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 527 Total Citation Count
- Apr 10, 1995 Earliest Filing
- 26 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0240,638 ENHANCING THE THERAPEUTIC ACTIVITY OF IMMUNE CHECKPOINT INHIBITORFeb 17, 17Aug 24, 17[A61K, C07K]
2017/0065,716 ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT INHIBITORJun 01, 16Mar 09, 17[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9890208 Compositions and methods for treating inflammation and fibrosisSep 17, 14Feb 13, 18[A61K, C07K]
9220746 Compounds and methods for treating bone disorders and controlling weightJun 04, 10Dec 29, 15[A61K, A61P, C07K]
9050296 Methods for treating metabolic syndrome with Cthrc1 polypeptideJul 03, 13Jun 09, 15[A61K, G01N, A01K, A61P, C07K]
8710099 Treatment of cancer using the sodium salt of a benzoic acid derivativeSep 10, 10Apr 29, 14[A61K, C07C]
8349559 System and method for identifying erythropoietin-responsive genesJan 25, 10Jan 08, 13[C12Q, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0237,504 COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND FIBROSISAbandonedOct 14, 10Sep 20, 12[A61K, A61P]
8173613 Modulation of mesenchymal and metastatic cell growthExpiredSep 22, 06May 08, 12[A61K, C07H, C12N]
7541431 Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating theretoExpiredAug 17, 06Jun 02, 09[C07K]
2009/0123,565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating theretoAbandonedMay 22, 06May 14, 09[A61K]
7501281 Compositions, methods and kits related to thrombin, Notch signaling and stamatogenesis and growth of stem cellsExpiredAug 22, 05Mar 10, 09[C12N]
2008/0193,942 System and method for identifying erythropoietin-responsive genesAbandonedNov 06, 07Aug 14, 08[C12Q, C12N, G01N]
2008/0172,214 System For Optimizing Treatment Strategies Using a Patient-Specific Rating SystemAbandonedAug 26, 05Jul 17, 08[G06Q, G06G]
7304138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acidsExpiredAug 28, 03Dec 04, 07[C07K]
2006/0084,599 Compositions, methods and kits relating to notch signalingAbandonedFeb 10, 05Apr 20, 06[A61K, C07K]
6982170 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1ExpiredDec 17, 01Jan 03, 06[C12N]
2005/0147,602 Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrixAbandonedSep 10, 04Jul 07, 05[C07H, A61K, A01K, C07K]
6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acidsExpiredAug 06, 02Nov 30, 04[C07H, C12P, C12N]
2004/0229,796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating theretoAbandonedFeb 23, 04Nov 18, 04[A61K]
2004/0203,018 Compositions and methods relating to control DNA constructAbandonedAug 14, 03Oct 14, 04[C07H, C12Q]
2004/0071,787 Pharmacologic, therapeutic and diagnostic regulation of FGF-1 exportAbandonedMar 06, 03Apr 15, 04[A61K]
6716974 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acidsExpiredMay 24, 00Apr 06, 04[C07H]
2004/0063,176 Compositions, methods and kits relating to remodelAbandonedAug 04, 03Apr 01, 04[C07H, C12P, C12N]
6607911 Compositions and methods relating to control DNA constructExpiredMay 25, 01Aug 19, 03[C07H, C12Q, C12P, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.